Goldman Sachs Slams Intuit: Downgraded to Sell as AI Tax Apps Threaten TurboTax
Goldman Sachs cut Intuit to Sell, warning AI tax rivals may reduce growth, profits, and TurboTax market share.
NOTRELOAD AI
Turnaround in Full Swing: Victoria’s Secret Shares Jump on Earnings Blowout
Victoria’s Secret surged after strong Q1 results beat forecasts and it raised 2026 sales and profit outlook. Turnaround is working.
FDA Delays Cingulate’s ADHD Drug Approval – But No Safety or Efficacy Issues
FDA asked Cingulate to fix manufacturing details for ADHD drug; no safety issues. Company will update and resubmit soon.
Dollar General Jumps as Q1 EPS Beats Estimates & Raises Full-Year Profit Outlook
Dollar General beat Q1 estimates, raised outlook, higher sales and profit; stock up premarket but still down YTD.
Cancer Cases Cloud Abivax’s Landmark Phase 3 Win in Ulcerative Colitis
Abivax ulcerative colitis drug showed strong results, but cancer cases raised safety worries, sending shares down sharply.
Fulcrum Stock Crashes After Scrapping Sickle Cell Drug Over FDA Cancer Fears
Fulcrum stock dropped after canceling its sickle cell drug over cancer risk concerns; may sell company, $333M cash.